Clinical Trial Update: Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Children Suffering From Grass Pollen Rhinoconjunctivitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of a 300 IR grass pollen sublingual immunotherapy tablet in children with grass pollen rhinoconjunctivitis; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Grass pollen sublingual immunotherapy tablet 300 IR (sublingual immunotherapy tablet containing grass pollen extract (300 IR))

Snippet

Sponsor: Stallergenes Greer | Conditions: Allergy | Phase 3 | Status: COMPLETED | Results posted: 2016-05-26